Mar 03, 2026 .
ISPE Risk Model for RABS and Isolator Selection
ISPE-Aligned Risk Model for RABS and Isolator Selection
- Introduction
This is ISPE-aligned risk-based selection matrix for barrier technologies (Open RABS, Closed RABS, Isolators) that integrates the two orthogonal risk drivers you specified:
- Sterility Assurance Risk (SAR) — contamination probability and level of operator intervention required; and
- Toxicological Containment Risk (TCR) — driven by OEB/OEL (Occupational Exposure Band / Occupational Exposure Limit).
The matrix and the selection logic are both based on the ISPE Baseline® Guide: Sterile Product Manufacturing Facilities, the ISPE Risk-MaPP Baseline Guide, and the ISPE Containment Manual (2nd Ed.) and related ISPE position material. ISPE Baseline® Guide: Sterile Product Manufacturing Facilities ISPE Risk‑Based Manufacture of Pharmaceutical Products (Risk‑MaPP) ISPE Containment Manual.
How to read the matrix
- SAR: divided into Low / Medium / High based on contamination probability and how many interventions (operator access, manipulations inside the critical zone) are required. Higher intervention frequency ⇒ higher SAR.
- TCR: mapped to OEB bands commonly used in ISPE/industry practice (OEB1–2 = low; OEB3 = moderate; OEB4 = high; OEB5 = very high). Where product toxicity (ADE/OEL) or regulatory guidance pushes toward containment, prefer more robust systems.
- The matrix cell shows the recommended primary technology and a short rationale. Use Risk-MaPP and ISPE Containment guidance to escalate controls where either SAR or TCR is high (the higher driver dominates).
Rationale / mapping to ISPE guidance
- Risk-MaPP logic: choose controls based on a documented risk assessment using health-based limits (ADE/OEL), exposure routes (airborne, mechanical), and failure modes — escalate controls (engineering > administrative) when risk cannot be reduced by procedures alone. This underpins selecting isolator over RABS when either SAR or TCR is high.
- Containment Manual / OEB: OEB banding (and OELs/ADEs) is the accepted way to convert toxicology into containment need. Higher OEBs (4–5) require engineered, validated containment (isolators or equivalent). ISPE containment materials explain planning by OEL/OEB and engineering controls.
- Sterile Baseline guide (Sterile facilities): the sterile baseline discusses RABS vs isolators (equipment design inside isolator/RABS, decontamination cycle development, EM expectations) and emphasizes minimizing interventions and validating decontamination — supporting the matrix emphasis on intervention frequency as a SAR driver.
Risk-Based Selection Matrix (SAR × TCR)
| SAR \ TCR (OEB) | OEB 1–2 (Low) | OEB 3 (Moderate) | OEB 4 (High) | OEB 5 (Very High) |
| Low SAR (few/no interventions; mostly closed/gowned operations; low airborne/mech transfer probability) | Open RABS possible — acceptable if cleaning/EM and SOPs proven; lower capital cost. Use area grade and environmental monitoring per ISPE sterile guidance. Rationale: Low SAR + low toxicity → barrier benefit but not mandatory. | Closed RABS recommended — provides a full/near-full barrier, reduces intervention risk and airborne ingress while remaining less complex than isolators. Use validated cleaning/disinfection and validated transfer ports. | Closed RABS permissible with strong controls — only if validated decontamination /transfer methods and documented performance place airborne/mechanical transfer below acceptable limits. Otherwise escalate to isolator. Rationale: moderate toxicity demands stronger containment. | Isolator required — for high potency (OEB5) prefer closed, sealed isolator with validated VHP or equivalent decontamination cycles and controlled transfer systems (pass-throughs, double-containment). Manual interventions must be minimized. |
| Medium SAR (occasional interventions; some open manipulations; moderate contamination probability) | Closed RABS recommended — interventions increase contamination risk; closed RABS reduces operator access and airborne movement relative to open RABS. Ensure aseptic process validation, EM and SOPs. | Closed RABS or Isolator — prefer Closed RABS if validated processes, transfers and reproducible disinfection exist; Isolator preferred if interventions are moderately frequent or product microbial sensitivity is high. Use a documented QRM justification (Risk-MaPP). | Isolator recommended — medium–high SAR combined with high toxicity generally requires isolator level segregation to prevent cross-contamination and protect operators. Automated decon cycles and validated seals required. | Isolator required (mandatory choice) — medium intervention plus very high toxicity is unacceptable with RABS; isolate the process. Validate containment (air monitoring, leak pressure testing, glove integrity strategies). |
| High SAR (frequent/complex interventions; open fills, many manipulations; high contamination probability) | Closed RABS (only if minimal interventions) otherwise Isolator — if interventions truly frequent, closed RABS unlikely to control microbiological risk; isolator favored. Provide QRM evidence if selecting RABS. | Isolator recommended — high intervention frequency drives need for operator separation; isolator reduces human-related contamination sources and supports validated decontamination. | Isolator required — high SAR + high toxicity = isolator with validated, automated decontamination and tight transfer control. Multi-layer containment and engineering controls per ISPE Containment Manual. | Isolator mandatory, highest integrity design — automated decontamination between campaigns, robust transfer / glove port strategies, routine integrity/HEPA checks, continuous monitoring; consider dedicated facility if multiproduct with incompatible toxicology. |
Practical implementation notes (what to document / validate)
- Documented QRM (Risk-MaPP style): record how SAR and TCR were assessed, thresholds chosen, and why the selected technology meets the risk objective. Include ADE/OEL derivation, exposure routes, and intervention tally.
- Acceptance criteria: define contamination probability targets (e.g., zero interventions during critical period, action levels for EM) and airborne/particle limits; these feed acceptance/commissioning tests. Use Sterile Baseline EM expectations.
- Containment validation: for isolators, validate decontamination (e.g., VHP cycles), transfer port containment, glove integrity strategy, and recovery after simulated interventions. For closed RABS, validate barrier performance, transfer methods, and disinfection reproducibility. Use Containment Manual recommendations for filter handling, leak testing, and exposure measurements.
- Operational controls & monitoring: continuous/periodic monitoring (EM, pressure decay/leak checks, glove integrity checks), robust SOPs for interventions, and change control. Risk-MaPP emphasizes lifecycle risk management.
Quick decision checklist (one-page)
- Is product toxicity OEB ≥ 4 (or OEL < ~10 µg/m³)? → strongly favor Isolator.
- Are required interventions frequent/complex in the critical zone? → favor Isolator.
- Can validated automated decontamination and sealed transfers be provided? If yes, Isolator is achievable; if not, consider closed RABS only for low–moderate TCR and low–medium SAR with robust QRM.
Assumptions & Caveats
- The matrix is a decision aid, not a prescriptive regulation. Final selection must be justified by local QRM using the Health-Based Limit (ADE/OEL), process-specific exposure data, and practical validation evidence (Risk-MaPP approach).
- OEB ranges shown are industry conventions (example bands: OEB5 <1 µg/m³; OEB4 ≈1–10 µg/m³; OEB3 ≈10–100 µg/m³). Use your facility’s adopted banding system and ADE/OEL derivation.
- Regulatory expectations (e.g., Annex 1 / FDA inspections) are increasingly focused on robust contamination control strategies and demonstrable validation — the matrix favors solutions that provide reproducible, validated barriers where required.
The Numerical Scoring Model (semi-quantitative QRM tool)
- The model produces a quantified recommendation between: Open RABS, Closed RABS, and Isolator using two orthogonal drivers:
- Sterility Assurance Risk (SAR)
- Toxicological Containment Risk (TCR)
Model Architecture
You will calculate: Total Barrier Requirement Index (BRI)
Where:
- Default weighting:
- w₁ (SAR) = 0.6
- w₂ (TCR) = 0.4
- If OEB ≥ 4 → automatically increase w₂ to 0.6 (containment-dominant case per Risk-MaPP philosophy)
Sterility Assurance Risk (SAR) Scoring
SAR is built from three subfactors:
| Parameter | Score 1 | Score 3 | Score 5 |
| Intervention Frequency | Rare / none | Occasional | Frequent / complex |
| Intervention Type | Fully remote | Glove access | Direct open manipulation |
| Aseptic Exposure Duration | <5 min | 5–30 min | >30 min |
Interpretation (SAR Range: 0–10)
| SAR Score | Category |
| 0–3 | Low |
| 3–6 | Medium |
| 6–10 | High |
Aligned with intervention minimization principles in the Sterile Baseline Guide.
- Toxicological Containment Risk (TCR)
Derived directly from OEB/OEL classification per ISPE Containment guidance and Risk-MaPP.
| OEB | Typical OEL Range | TCR Score |
| OEB 1 | >1000 µg/m³ | 1 |
| OEB 2 | 100–1000 µg/m³ | 3 |
| OEB 3 | 10–100 µg/m³ | 5 |
| OEB 4 | 1–10 µg/m³ | 8 |
| OEB 5 | <1 µg/m³ | 10 |
TCR range: 1–10
Technology Capability Index (TCI)
Each technology has an inherent capability rating:
| Technology | TCI (Max Acceptable BRI) |
| Open RABS | ≤ 4 |
| Closed RABS | ≤ 7 |
| Isolator | ≤ 10 |
- Decision Logic
After computing:
Apply containment dominance rule:
- If OEB ≥ 4 → automatically exclude Open RABS
- If OEB = 5 → Isolator mandatory
Then:
| BRI Result | Recommended Technology |
| 0–4 | Open RABS acceptable |
| 4–7 | Closed RABS recommended |
| >7 | Isolator required |
- Example Calculation
Case:
- Moderate interventions (3)
- Glove-based manipulation (3)
- Exposure ~20 min (3)
- OEB 4 product (TCR = 8)
SAR:
BRI:
Containment rule applies (OEB 4 → containment dominant).
Final Recommendation: Isolator
Even though numeric BRI suggests upper Closed RABS range, Risk-MaPP precautionary principle escalates to isolator.
